108
Participants
Start Date
June 30, 2001
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Insulin Asparte
Insulin asparte given 0.5 units per carb per meal
Repaglinide
0.5mg tab with meals tid
University of Minnesota Medical Center, Minneapolis
Stanford University, Palo Alto
Baystate Medical Center, Springfield
Children's Hospital of Pittsburgh, Pittsburgh
Vanderbilt University Medical Center, Nashville
University of Utah, Salt Lake City
St. Michael's Hospital, Toronto
Collaborators (1)
Cystic Fibrosis Foundation
OTHER
Novo Nordisk A/S
INDUSTRY
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH